TLR-dependent T cell activation in autoimmunity

Autoimmune disease can develop as a result of a breakdown in immunological tolerance, leading to the activation of self-reactive T cells. There is an established link between infection and human autoimmune diseases. Furthermore, experimental autoimmune diseases can be induced by autoantigens that are administered together with complete Freund's adjuvant, which contains killed Mycobacterium tuberculosis; in some cases, these bacteria can be replaced by individual pathogen-associated molecular patterns (PAMPs). Exogenous PAMPs and endogenous danger signals from necrotic cells bind to pattern recognition receptors (including Toll-like receptors) and activate signalling pathways in innate immune cells and in T cells. This leads to pro-inflammatory cytokine production and T cell activation, which are now considered to be major factors in the development of autoimmunity.

[1]  B. Becher,et al.  Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. , 2006, The Journal of clinical investigation.

[2]  L. Boon,et al.  Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1 , 2009, The Journal of Immunology.

[3]  M. Bevan,et al.  Cutting Edge: Lipopolysaccharide Induces IL-10-Producing Regulatory CD4+ T Cells That Suppress the CD8+ T Cell Response , 2007, The Journal of Immunology.

[4]  T. Giese,et al.  Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1 , 2002, The Journal of Immunology.

[5]  M. Feldmann,et al.  The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. , 2007, The American journal of pathology.

[6]  V. Tuohy,et al.  Encephalitogenicity of Complete Freund’s Adjuvant Relative to CpG Is Linked to Induction of Th17 Cells , 2009, The Journal of Immunology.

[7]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[8]  H. Einsele,et al.  Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope. , 1999, Arthritis and rheumatism.

[9]  L. Joosten,et al.  Toll-like receptor 2 controls expansion and function of regulatory T cells. , 2006, The Journal of clinical investigation.

[10]  E. Sasatomi,et al.  Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritisin mice , 2000, Immunology.

[11]  L. Boon,et al.  Infection with a Helminth Parasite Attenuates Autoimmunity through TGF-β-Mediated Suppression of Th17 and Th1 Responses1 , 2009, The Journal of Immunology.

[12]  J. Berzofsky,et al.  Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. , 2008, Immunity.

[13]  J. Bach,et al.  The effect of infections on susceptibility to autoimmune and allergic diseases. , 2002, The New England journal of medicine.

[14]  S. Akira,et al.  Cutting Edge: TLR2 Directly Triggers Th1 Effector Functions1 , 2007, The Journal of Immunology.

[15]  D. Fitzgerald,et al.  Cutting Edge: TLR3 Stimulation Suppresses Experimental Autoimmune Encephalomyelitis by Inducing Endogenous IFN-β1 , 2006, The Journal of Immunology.

[16]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[17]  S. Nakae,et al.  IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[18]  H. Einsele,et al.  Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis , 2004, Rheumatology International.

[19]  O. Leavy,et al.  Attenuating Regulatory T Cell Induction by TLR Agonists through Inhibition of p38 MAPK Signaling in Dendritic Cells Enhances Their Efficacy as Vaccine Adjuvants and Cancer Immunotherapeutics1 , 2008, The Journal of Immunology.

[20]  J. Ruland,et al.  Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17 , 2007, Nature Immunology.

[21]  H. Hooijkaas,et al.  The presence of peptidoglycan-polysaccharide complexes in the bowel wall and the cellular responses to these complexes in Crohn's disease. , 1994, Clinical immunology and immunopathology.

[22]  B. Segal,et al.  IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition , 2008, The Journal of experimental medicine.

[23]  B. Lazzaro,et al.  Danger, Microbes, and Homeostasis , 2011, Science.

[24]  S. Akira,et al.  HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses , 2009, Nature.

[25]  R. D. Hatton,et al.  Transforming growth factor-β induces development of the TH17 lineage , 2006, Nature.

[26]  Shimon Sakaguchi,et al.  Regulatory T cells exert checks and balances on self tolerance and autoimmunity , 2010, Nature Immunology.

[27]  G. Firestein,et al.  Immunostimulatory DNA Sequences Influence the Course of Adjuvant Arthritis1 , 2002, The Journal of Immunology.

[28]  F. Liew,et al.  Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[29]  K. Mills,et al.  Inhibition of ERK MAPK Suppresses IL-23- and IL-1-Driven IL-17 Production and Attenuates Autoimmune Disease1 , 2009, The Journal of Immunology.

[30]  R. Reynolds,et al.  Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain , 2007, The Journal of experimental medicine.

[31]  Clara Abraham,et al.  Interactions between the host innate immune system and microbes in inflammatory bowel disease. , 2011, Gastroenterology.

[32]  R. J. Hocking,et al.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.

[33]  James A. Thomas,et al.  Multiple toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity , 2006, Journal of Neuroimmunology.

[34]  C. Elson,et al.  Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis , 2010, The Journal of experimental medicine.

[35]  D. Strachan.  Family size, infection and atopy: the first decade of the 'hygiene hypothesis' , 2000, Thorax.

[36]  R. Hirsch,et al.  EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON , 1987, The Lancet.

[37]  R. Maizels,et al.  T-cell regulation in helminth parasite infections: implications for inflammatory diseases. , 2008, Chemical immunology and allergy.

[38]  K. Mills,et al.  TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours , 2008, Oncogene.

[39]  F. Gusovsky,et al.  Inhibition of Endotoxin Response by E5564, a Novel Toll-Like Receptor 4-Directed Endotoxin Antagonist , 2003, Journal of Pharmacology and Experimental Therapeutics.

[40]  D. Pardoll,et al.  Persistent Toll-like receptor signals are required for reversal of regulatory T cell–mediated CD8 tolerance , 2004, Nature Immunology.

[41]  A. Mildner,et al.  Streptococcus pneumoniae Infection Aggravates Experimental Autoimmune Encephalomyelitis via Toll-Like Receptor 2 , 2006, Infection and Immunity.

[42]  V. Kuchroo,et al.  Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. , 2004, The Journal of clinical investigation.

[43]  L. Joosten,et al.  Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. , 2007, Arthritis and rheumatism.

[44]  Y. Iwakura,et al.  Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category , 2008, The Journal of experimental medicine.

[45]  R Balfour Sartor,et al.  Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. , 2008, Cell host & microbe.

[46]  M. Lynch,et al.  Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis , 2010, Brain, Behavior, and Immunity.

[47]  A. Kimball,et al.  Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1) , 2008, The Lancet.

[48]  Ruslan Medzhitov,et al.  Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells , 2003, Science.

[49]  K. Mills,et al.  TLR4 Mediates Vaccine-Induced Protective Cellular Immunity to Bordetella pertussis: Role of IL-17-Producing T Cells1 , 2006, The Journal of Immunology.

[50]  Masahiro Yamamoto,et al.  ATP drives lamina propria TH17 cell differentiation , 2008, Nature.

[51]  K. Mills,et al.  Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. , 2009, Immunity.

[52]  S. Holdsworth,et al.  Toll-like receptor 2 induces Th17 myeloperoxidase autoimmunity while Toll-like receptor 9 drives Th1 autoimmunity in murine vasculitis. , 2011, Arthritis and rheumatism.

[53]  P. Tak,et al.  Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines. , 2000, Arthritis and rheumatism.

[54]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[55]  H. Wiendl,et al.  CD8+ T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[57]  K. Mills,et al.  Caspase-1–Processed Cytokines IL-1β and IL-18 Promote IL-17 Production by γδ and CD4 T Cells That Mediate Autoimmunity , 2011, The Journal of Immunology.

[58]  Christophe Benoist,et al.  Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. , 2010, Immunity.

[59]  G. Steiner,et al.  Nucleic acid-stimulated antigen-presenting cells trigger T cells to induce disease in a rat transfer model of inflammatory arthritis. , 2011, Journal of autoimmunity.

[60]  D. Jarrossay,et al.  Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.

[61]  J. Oppenheim,et al.  Alarmins: chemotactic activators of immune responses. , 2005, Current opinion in immunology.

[62]  Yongsoo Park,et al.  Association of the Polymorphism for Toll‐like Receptor 2 with Type 1 Diabetes Susceptibility , 2004, Annals of the New York Academy of Sciences.

[63]  K. Kumagai,et al.  Induction of Acute Arthritis in Mice by Peptidoglycan Derived from Gram‐Positive Bacteria and Its Possible Role in Cytokine Production , 1993, Microbiology and immunology.

[64]  A. Roberts,et al.  Regulation of interleukin‐1β by interferon‐γ is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin‐17 production , 2010, EMBO reports.

[65]  L. Tam,et al.  Activation profile of Toll‐like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus , 2010, Clinical and experimental immunology.

[66]  A. Gurney,et al.  Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17* , 2003, The Journal of Biological Chemistry.

[67]  L. Joosten,et al.  Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. , 2008, The Journal of clinical investigation.

[68]  S. Dasgupta,et al.  Central Nervous System Demyelinating Disease Protection by the Human Commensal Bacteroides fragilis Depends on Polysaccharide A Expression , 2010, The Journal of Immunology.

[69]  박주홍,et al.  The Toll-Like Receptor 2 pathway Establishes Colonization by a Commensal of the Human Microbiota , 2011 .

[70]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[71]  I. Caramalho,et al.  Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide , 2003, The Journal of experimental medicine.

[72]  J. Langtry,et al.  Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas , 2006, Clinical and experimental dermatology.

[73]  Weiyi Peng,et al.  Toll-Like Receptor 8-Mediated Reversal of CD4+ Regulatory T Cell Function , 2005, Science.

[74]  M. Levings,et al.  Human CD4+ T Cells Express TLR5 and Its Ligand Flagellin Enhances the Suppressive Capacity and Expression of FOXP3 in CD4+CD25+ T Regulatory Cells1 , 2005, The Journal of Immunology.

[75]  C. Tato,et al.  Lymphoid tissue inducer–like cells are an innate source of IL-17 and IL-22 , 2009, The Journal of experimental medicine.

[76]  R. Hintzen,et al.  Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates. , 2006, The American journal of pathology.

[77]  J. Correale,et al.  The risk of relapses in multiple sclerosis during systemic infections , 2006, Neurology.

[78]  K. Mills,et al.  TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine Adjuvants , 2010, Current infectious disease reports.

[79]  T. Owens,et al.  Interferon‐γ confers resistance to experimental allergic encephalomyelitis , 1996, European journal of immunology.

[80]  A. Rachitskaya,et al.  Cutting Edge: NKT Cells Constitutively Express IL-23 Receptor and RORγt and Rapidly Produce IL-17 upon Receptor Ligation in an IL-6-Independent Fashion1 , 2008, The Journal of Immunology.

[81]  Xiang Chen,et al.  Expression of High Mobility Group Box Chromosomal Protein 1 and Its Modulating Effects on Downstream Cytokines in Systemic Lupus Erythematosus , 2010, The Journal of Rheumatology.

[82]  R. D. Hatton,et al.  Regulatory T Cell Suppression and Anergy Are Differentially Regulated by Proinflammatory Cytokines Produced by TLR-Activated Dendritic Cells1 , 2004, The Journal of Immunology.

[83]  M. Kurrer,et al.  TLR Ligands Act Directly upon T Cells to Restore Proliferation in the Absence of Protein Kinase C-θ Signaling and Promote Autoimmune Myocarditis1 , 2007, The Journal of Immunology.

[84]  Thomas Kamradt,et al.  Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. , 2005, Trends in immunology.

[85]  Polly Matzinger,et al.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses , 2004, Nature Reviews Immunology.

[86]  T. Mcclanahan,et al.  Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation , 2003, The Journal of experimental medicine.

[87]  O. Kämpe,et al.  Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis , 2008, European journal of immunology.

[88]  Chen Dong,et al.  Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. , 2010, Immunity.

[89]  A. Billiau,et al.  Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. , 1997, Journal of immunology.

[90]  A. Forbes,et al.  Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn’s disease , 2005, Gut.

[91]  T. Merriman,et al.  TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort , 2007, Journal of gastroenterology and hepatology.

[92]  R. Xu,et al.  A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. , 2009, American Journal of Physiology - Gastrointestinal and Liver Physiology.

[93]  B. Segal,et al.  Activation of APCs Through CD40 or Toll-Like Receptor 9 Overcomes Tolerance and Precipitates Autoimmune Disease1 , 2002, The Journal of Immunology.

[94]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[95]  M. Veldhoen,et al.  Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. , 2009, Immunity.

[96]  Graham M Lord,et al.  Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes , 2007, Proceedings of the National Academy of Sciences.

[97]  R. J. Hocking,et al.  Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease , 2006, Nature Immunology.

[98]  M. Bianchi.  DAMPs, PAMPs and alarmins: all we need to know about danger , 2007, Journal of leukocyte biology.

[99]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[100]  A. Rachitskaya,et al.  NKT cells constitutively express IL‐23 receptor and RORγt, and rapidly produce IL‐17 upon receptor ligation in an IL‐6‐independent fashion , 2008 .

[101]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[102]  D. Persing,et al.  A Synthetic TLR4 Antagonist Has Anti-Inflammatory Effects in Two Murine Models of Inflammatory Bowel Disease 1 , 2005, The Journal of Immunology.

[103]  W. Hop,et al.  Prospective study on the relationship between infections and multiple sclerosis exacerbations. , 2002, Brain : a journal of neurology.

[104]  A. So,et al.  TLR2 modulates inflammation in zymosan-induced arthritis in mice , 2005, Arthritis research & therapy.

[105]  R. Ravid,et al.  Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis. , 2001, Brain : a journal of neurology.

[106]  K. Mills.  Induction, function and regulation of IL‐17‐producing T cells , 2008, European journal of immunology.

[107]  W. Born,et al.  gammadelta T cells: an important source of IL-17. , 2008, Current opinion in immunology.

[108]  S. Akira,et al.  TLR2 engagement on CD8 T cells lowers the thresholdfor optimal antigen‐induced T cell activation , 2006, European journal of immunology.

[109]  S. Akira,et al.  Identification of a key pathway required for the sterile inflammatory response triggered by dying cells , 2007, Nature Medicine.

[110]  D. Hommes,et al.  Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. , 2007, Immunity.

[111]  Andrew E. Parker,et al.  Targeting Toll-like receptors: emerging therapeutics? , 2010, Nature Reviews Drug Discovery.

[112]  S. Su,et al.  Essential Role of the MyD88 Pathway, but Nonessential Roles of TLRs 2, 4, and 9, in the Adjuvant Effect Promoting Th1-Mediated Autoimmunity , 2005, The Journal of Immunology.

[113]  L. Cosmi,et al.  Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.

[114]  P. Doevendans,et al.  Myocardial Ischemia / Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti – Toll-Like Receptor-2 Antibody , 2009 .

[115]  Kun Wook Chung,et al.  Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. , 2007, Immunity.

[116]  S. Su,et al.  The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model. , 2010, Investigative ophthalmology & visual science.

[117]  R. Ravid,et al.  Broad Expression of Toll‐Like Receptors in the Human Central Nervous System , 2002, Journal of neuropathology and experimental neurology.

[118]  K. Mills,et al.  A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitis , 2006, The Journal of experimental medicine.

[119]  H. Weiner,et al.  Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE , 2009, Nature Immunology.